Guardian Capital LP Bausch Health Companies Inc. Transaction History

Guardian Capital LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$7.06 - $23.63 $27.4 Million - $91.8 Million	-3,884,769 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$21.6 - $27.79 $1.11 Million - $1.43 Million	51,439 Added 1.34%	3,884,769 $88.8 Million
Q4 2021 Feb 10, 2022	SELL	$23.0 - $29.01 $10.6 Million - $13.3 Million	-460,116 Reduced 10.72%	3,833,330 $106 Million
Q3 2021 Nov 15, 2021	SELL	$25.04 - $30.06 $15.4 Million - $18.5 Million	-613,961 Reduced 12.51%	4,293,446 $120 Million
Q2 2021 Aug 17, 2021	BUY	$27.43 - $32.7 $16.2 Million - $19.3 Million	591,054 Added 13.69%	4,907,407 $144 Million
Q1 2021 May 17, 2021	SELL	$21.37 - $34.38 $17.2 Million - $27.6 Million	-803,921 Reduced 15.7%	4,316,353 $172 Million
Q4 2020 Feb 12, 2021	BUY	$15.31 - $21.12 $22.5 Million - $31 Million	1,469,474 Added 40.25%	5,120,274 $106 Million
Q3 2020 Nov 16, 2020	BUY	$14.88 - $20.13 $8.71 Million - $11.8 Million	585,600 Added 19.1%	3,650,800 $56.6 Million
Q2 2020 Aug 13, 2020	BUY	$13.31 - $20.51 $40.8 Million - $62.9 Million	3,065,200 New	3,065,200 $55.9 Million

272

280M

5.68M

17.4M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.33B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Guardian Capital LP, based on Form 13F filings with the SEC.

Stay updated on Guardian Capital LP with notifications on news.